Questions: Effect Modification and Statistical Interaction
5 questions to test your understanding
Score: 0 / 5
Question 1 Multiple Choice
A stratified analysis of aspirin and myocardial infarction risk shows RR = 0.65 in men over 50 and RR = 1.02 in pre-menopausal women. A colleague argues you should adjust for sex and report a single overall estimate. What is the correct response?
AAgree — adjusting for sex removes the confounding and reveals the true aspirin effect
BAgree — the stratum-specific estimates are too heterogeneous to be reliable individually
CDisagree — the divergent stratum-specific estimates indicate effect modification, and collapsing them into a single adjusted estimate would obscure genuine biological heterogeneity
DDisagree — adjustment is unnecessary since sex is not associated with aspirin use in this study
When stratum-specific estimates differ substantially, this is effect modification — the exposure effect genuinely varies across levels of the stratifying variable. Pooling or adjusting produces a meaningless average that misrepresents the truth in both groups: aspirin is protective in older men and neutral in pre-menopausal women. Adjusting to remove effect modification would be scientifically incorrect. The right action is to report stratum-specific estimates and investigate the biological mechanism (hormonal differences, cardiovascular risk profiles). This differs from confounding, where adjustment is appropriate because the stratum-specific estimates agree with each other.
Question 2 Multiple Choice
A stratified analysis of physical activity and diabetes risk shows RR = 0.61 in men and RR = 0.60 in women, while the crude (unadjusted) RR = 0.76. This pattern most strongly suggests:
AEffect modification by sex — physical activity protects men and women differently
BConfounding by sex — sex is associated with both physical activity levels and diabetes risk, distorting the crude estimate
CNeither confounding nor effect modification — the crude and adjusted estimates are similar enough to ignore
DEffect modification that operates on the multiplicative but not the additive scale
The key diagnostic pattern: stratum-specific estimates agree with each other (0.61 ≈ 0.60) but both differ from the crude estimate (0.76). This is the fingerprint of confounding, not effect modification. Sex is acting as a confounder — it distorts the crude estimate because it is associated with both the exposure (men and women have different activity levels) and the outcome (sex differences in diabetes risk). Adjusting for sex corrects the crude estimate toward the true effect (~0.60–0.61). If there were effect modification, the stratum-specific estimates would diverge from each other.
Question 3 True / False
Effect modification is a form of bias that distorts the true association between exposure and outcome and should be removed using statistical adjustment, just like confounding.
TTrue
FFalse
Answer: False
This is the central conceptual error in the confounding/effect modification distinction. Effect modification is not bias — it reflects real, genuine heterogeneity in the exposure effect across subgroups. The 'distortion' is biological truth, not a statistical artifact. The appropriate response to effect modification is to preserve and report the stratum-specific estimates, not to eliminate them by adjustment. Adjustment in the presence of true effect modification produces a misleading single number that is literally incorrect for every subgroup it purports to summarize. Confounding is the concept where bias exists and adjustment is warranted.
Question 4 True / False
A statistical interaction that appears significant on the additive scale (risk differences) may be absent or even reversed when examined on the multiplicative scale (risk ratios).
TTrue
FFalse
Answer: True
Statistical interaction is scale-dependent. Consider two groups with risks: A alone = 0.10, B alone = 0.20, A+B together = 0.30. On the additive scale, the joint effect equals the sum of individual effects (0.10 + 0.20 = 0.30), so no additive interaction. On the multiplicative scale, you might still find statistical interaction depending on how you parameterize the model. Conversely, the same data might show additive interaction without multiplicative interaction. This scale-dependence is why epidemiologists must specify which scale they are using: additive interaction is usually more relevant for identifying high-risk subgroups for intervention (absolute risk matters for public health), while multiplicative interaction is common in etiological research.
Question 5 Short Answer
What is the key practical difference between how an epidemiologist should respond when stratified analysis reveals confounding versus when it reveals effect modification?
Think about your answer, then reveal below.
Model answer: When stratified analysis reveals confounding: the stratum-specific estimates agree with each other but differ from the crude estimate. The crude estimate is biased, and the correct action is to report the adjusted (pooled) estimate that removes the confounder's distorting influence. When stratified analysis reveals effect modification: the stratum-specific estimates differ substantially from each other. The crude estimate is misleading not because of bias but because the exposure truly affects different subgroups differently. The correct action is to report stratum-specific estimates separately — pooling or adjusting would destroy the information. The same statistical tool (stratification) diagnoses both, but the response is opposite: for confounding, collapse; for effect modification, separate.
A useful memory aid: confounding says 'the crude estimate is wrong, fix it'; effect modification says 'no single estimate is right, report both.' The test is whether stratum-specific estimates agree. Agreement = confounding (compare crude vs. adjusted). Disagreement = effect modification (the variation is the result). Researchers who always pool results may hide important effect modification that could reveal who benefits from a treatment and who does not — information critical for clinical decision-making and targeted public health interventions.